“The Cambodian Ministry of Health is fully committed to implementing the NCCP to expand the range of service delivery and ...

Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and ...

Learn how radiopharmaceuticals are transforming nuclear medicine and cancer therapy through targeted diagnostics and ...

South Korea has received approval for domestic production and supply of radioisotopes Actinium(Ac-225) and Iodine (I-131) used for cancer treatment, after long depending ...

Health Cabinet Secretary Aden Duale has instructed national referral hospitals, the Social Health Authority (SHA), and the ...

The ERVI is reviewing the EU's production capacity for metallic HALEU. It is also looking at ways to enhance the production ...

RAD202 and RAD204 leverage Radiopharm’s nanobody construct offering a more versatile approach compared to full size antibodies along with the Lutetium-177 radioisotope. Both are the subject of ...

A radionuclide treatment for non-melanoma skin cancer is well tolerated and effective for patients with shallow skin lesions, according to researchers.

As previously announced, the FDA also granted iopofosine I 131 Fast Track Designation and Orphan Drug Designation. The ...

One year after becoming the first centre to open a global clinical trial of a radioligand therapy for metastatic prostate ...

Song, Z. and Zhong, W. (2025) Research Advances in Subtype Classification and Diagnosis of Primary Aldosteronism. Journal of Biosciences and Medicines, 13, 1-11. doi: 10.4236/jbm.2025.136001 .